| Mutation type:Point | Mutation effect:Missense | Nucleotide number:211 | |||
| Genome location:Exon3 | Subdomain:Gla | ||||
| Alpha missense prediction value:0.6691 | Alpha missense prediction class:pathogenic | ||||
| No. of patients reported: 2 | |||||
| Patient information: Monoallelic variation (2); Biallelic variation (0) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | NA | hetero | NA | NA | NA | II | DVT, Other VTE | NA | China | PVT (Other VTE) | PMID: 22951146 |
| 2 | M | NA | hetero | 56 | NA | 85 | II | Other VTE | NA | China | PVT (Other VTE); Anticoagulation, thrombolysis and other treatments | PMID: 22366017 |
| Mutation type:Point; Point | Mutation effect:Missense; Missense | Nucleotide number:211; 565 | |||
| Genome location:Exon3; Exon7 | Subdomain:Gla; Linker | ||||
| Alpha missense prediction value:0.6691; 0.0952 | Alpha missense prediction class:pathogenic; benign | ||||
| No. of patients reported: 2 | |||||
| Patient information: Monoallelic variation (0); Biallelic variation (2) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 20 | c.hetero | 19 | NA | 42 | NA | PE (19) | 19 | China | NA | PMID: 22951146 |
| 2 | M | 19 | c.hetero | 19 | NA | 42 | II | PE | 19 | China | LMWH, thrombolysis, anticoagulation therapy | PMID: 22366017 |